Circadian Rhythm Monitoring Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorResMed

About this trial

This will be a single-center, prospective observational study designed to evaluate the feasibility and accuracy of a new wearable device for non-invasive continuous monitoring of physiological signals to derive circadian rhythm. Melatonin sampling will be included for comparison against wearable-derived measures

Eligibility criteria

Qualifiers

Adults ≥18 years at screening.

Able and willing to provide written informed consent.

Belonging to one of three strata: (a) healthy controls without diagnosed sleep disorder, (b) patients with physician-diagnosed OSA, or (c) patients with physician-diagnosed insomnia (based on DSM-5/AASM criteria and ISI ≥15)

Capable of using a smartphone for app-based data syncing.

Disqualifiers

• Dermatologic conditions preventing wearable use.

Significant psychiatric or neurologic illness that may impair compliance.

Shift work or trans-meridian travel within 2 weeks prior.

Currently pregnant

Trial design

Treatments tested in this trial

  • Circadian monitoring device

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators